Compare Medpace Holdings Inc (MEDP) vs Trade Desk Inc (TTD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Trade Desk Inc — how do they compare? Medpace Holdings Inc trades at $612.05 (market cap $16.82B), while Trade Desk Inc trades at $12.08 (market cap $5.83B). The key difference: Medpace Holdings Inc is far larger — about 2.9× Trade Desk Inc's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, Trade Desk Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Medpace Holdings Inc for 14 Days and Trade Desk Inc for 72 Days on average.
| MEDP | TTD | |
|---|---|---|
Market Cap | $16.82B | $5.83B |
Volume | 223,093 | 15,864,392 |
Sector | Health | Media |
52-Week High | $630.19 | $54.13 |
52-Week Low | $393.42 | $11.92 |
Typical Hold Time | 14 Days | 72 Days |
Enterprise Value | $16.44B | $4.78B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $612.05, up 1.29% today, near its consensus price target of $620.44. The stock shows strong profitability with a 17.67% net margin and has beaten earnings estimates for the last three quarters. Technical indicators are neutral overall, with support at $595 and resistance at $612. Recent news highlights CEO stock sales and institutional position changes, while the company prepares to report Q3 2026 results on October 21.
Outlook remains positive given consistent earnings beats and projected revenue growth to $2.8B in 2026. Risks include high valuation multiples (P/E 35.41) and insider selling. Analyst consensus is cautious with 79% hold ratings, suggesting limited near-term upside but solid fundamental support for long-term holders.
The Trade Desk (TTD) trades at $12.34, up 2.07% today but remains down significantly from recent highs. Technical indicators show a bearish trend with mixed momentum signals. Fundamentally, the company maintains strong profitability with 76.87% gross margins and 15.44% ROE, though revenue growth has slowed to 3% in 2026. Recent news highlights competitive pressures from Amazon and Alphabet while the company navigates workforce reductions and slower CTV growth.
Investment outlook remains cautious with analyst consensus at $14.72 target price representing 19% upside potential. Key opportunities include TTD's dominant position in programmatic advertising and healthy cash flow generation. Primary risks involve intensifying competition from tech giants, slowing revenue growth, and execution challenges during restructuring. The stock presents a value opportunity for patient investors if competitive pressures ease.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Trade Desk Inc
The Trade Desk Inc is engaged in providing a technology platform for ad buyers. Through its cloud-based platform ad buyers can create, manage, and optimize data-driven digital advertising campaigns across ad formats and channels, including display, video, audio, in-app, native and social, on a multitude of devices. Its products include Data Management Platform, Cross-Device Targeting, Video Advertising, Mobile Advertising, and others.
Read more on TTD →
